Nasdaq
$2.50▼ 3.85%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $8.7MShares out 3.5M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
11- 10.9After-hours26.10.10 06:158-KKey event#●●●#●●●
ARTELO BIOSCIENCES, INC.
Artelo Biosciences has been identified as falling below Nasdaq's new $5 million Market Value of Listed Securities (MVLS) requirement. The rule is currently under a temporary stay, and the company intends to monitor developments and consider potential actions, such as capital raising, to maintain compliance if the rule is reinstated.…more
$2.50-3.85%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.27Pre-market26.08.27 21:308-KKey event
ARTELO BIOSCIENCES, INC.
Artelo Biosciences has implemented a 1-for-9 reverse stock split to improve the marketability and liquidity of its common stock. As a result, the total number of outstanding shares will be reduced from 4,929,966 to approximately 547,774, with split-adjusted trading commencing on August 31, 2026.…more
$2.50-3.85%vs prev closeView filingShare - 8.20After-hours26.08.21 05:3010-Q/AEarnings
ARTELO BIOSCIENCES, INC.
Artelo Biosciences filed an amendment to its 10-Q for the quarter ended June 30, 2026, to disclose a FINRA arbitration claim filed by Craft Capital Management. The claimant is seeking $880,000 in success fees and warrants related to an $11 million private placement, while the company filed counterclaims on July 7, 2026, regarding the dispute.…more
$2.50-3.85%vs prev closeView filingShare
10 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.7Pre-market26.10.07 21:48#●●●#●●●
Artelo Biosciences to Present Clinical Progress at BIO-Europe 2026
Artelo Biosciences has been selected to showcase its lead candidate ART26.12 and clinical progress at the upcoming BIO-Europe 2026 conference. The company aims to leverage this platform to advance business development and explore potential partnership opportunities.…more
$2.50-3.85%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.23Pre-market26.09.23 20:33
●●●●●●●● ●●●●● ●●●●●●
Artelo Biosciences has filed a provisional patent for its candidate ART27.13 as a treatment for obesity. While the company reported positive nonclinical weight loss results, these findings are preliminary and require further clinical validation.…more
$2.50-3.85%vs prev close - 9.16Regular26.09.17 00:39
●●●●●●●● ●●●●● ●●●●●●
Artelo Biosciences announced nonclinical data showing its cannabinoid drug candidate doubled weight loss when combined with a popular GLP-1 treatment. Despite the findings, the company's stock experienced a significant decline following the announcement.…more
$2.50-3.85%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report